001     201298
005     20240625095113.0
024 7 _ |2 doi
|a 10.1002/prot.24047
024 7 _ |2 ISSN
|a 0887-3585
024 7 _ |2 ISSN
|a 1097-0134
024 7 _ |2 WOS
|a WOS:000303759000004
037 _ _ |a FZJ-2015-03603
041 _ _ |a English
082 _ _ |a 540
100 1 _ |0 P:(DE-HGF)0
|a Fenollar-Ferrer, Cristina
|b 0
|e Corresponding Author
245 _ _ |a Insights on the acetylated NF-κB transcription factor complex with DNA from molecular dynamics simulations
260 _ _ |a New York, NY
|b Wiley-Liss
|c 2012
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1434006399_12148
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
520 _ _ |a The nuclear factor-κB (NF-κB) is a DNA sequence-specific regulator of many important biological processes, whose activity is modulated by enzymatic acetylation. In one of the best functionally characterized NF-κB complexes, the p50/p65 heterodimer, acetylation of K221 at p65 causes a decrease of DNA dissociation rate, whilst the acetylation of K122 and K123, also at p65, markedly decreases the binding affinity for DNA. By means of molecular dynamics simulations based on the X-ray structure of the p50/p65 complex with DNA, we provide insights on the structural determinants of the acetylated complexes in aqueous solution. Lysine acetylation involves the loss of favorable electrostatic interactions between DNA and NF-κB, which is partially compensated by the reduction of the desolvation free-energy of the two binding partners. Acetylation at both positions K122 and K123 is associated with a decrease of the electrostatic potential at the p65/DNA interface, which is only partially counterbalanced by an increase of the local Na+ concentration. It induces the disruption of base-specific and nonspecific interactions between DNA and NF-κB and it is consistent with the observed decrease of binding affinity. In contrast, acetylation at position K221 results in the loss of nonspecific protein–DNA interactions, but the DNA recognition sites are not affected. In addition, the loss of protein–DNA interactions is likely to be counterbalanced by an increase of the configurational entropy of the complex, which provides, at a speculative level, a justification for the observed decrease of NF-κB/DNA dissociation rate
536 _ _ |0 G:(DE-HGF)POF2-899
|a 899 - ohne Topic (POF2-899)
|c POF2-899
|x 0
|f POF I
588 _ _ |a Dataset connected to CrossRef, juser.fz-juelich.de
700 1 _ |0 P:(DE-HGF)0
|a Anselmi, Claudio
|b 1
700 1 _ |0 P:(DE-HGF)0
|a Carnevale, Vincenzo
|b 2
700 1 _ |0 P:(DE-HGF)0
|a Raugei, Simone
|b 3
700 1 _ |0 P:(DE-Juel1)145614
|a Carloni, Paolo
|b 4
|u fzj
773 _ _ |0 PERI:(DE-600)1475032-6
|a 10.1002/prot.24047
|g Vol. 80, no. 6, p. 1560 - 1568
|n 6
|p 1560 - 1568
|t Proteins
|v 80
|x 0887-3585
|y 2012
856 4 _ |u https://juser.fz-juelich.de/record/201298/files/24047_ftp.pdf
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/201298/files/24047_ftp.gif?subformat=icon
|x icon
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/201298/files/24047_ftp.jpg?subformat=icon-1440
|x icon-1440
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/201298/files/24047_ftp.jpg?subformat=icon-180
|x icon-180
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/201298/files/24047_ftp.jpg?subformat=icon-640
|x icon-640
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/201298/files/24047_ftp.pdf?subformat=pdfa
|x pdfa
|y Restricted
909 C O |o oai:juser.fz-juelich.de:201298
|p VDB
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)145614
|a Forschungszentrum Jülich GmbH
|b 4
|k FZJ
913 2 _ |0 G:(DE-HGF)POF3-899
|1 G:(DE-HGF)POF3-890
|2 G:(DE-HGF)POF3-800
|a DE-HGF
|b Forschungsbereich Materie
|l Forschungsbereich Materie
|v ohne Topic
|x 0
913 1 _ |0 G:(DE-HGF)POF2-899
|1 G:(DE-HGF)POF2-890
|2 G:(DE-HGF)POF2-800
|a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|v ohne Topic
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF2
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
915 _ _ |0 StatID:(DE-HGF)0110
|2 StatID
|a WoS
|b Science Citation Index
915 _ _ |0 StatID:(DE-HGF)0111
|2 StatID
|a WoS
|b Science Citation Index Expanded
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Thomson Reuters Master Journal List
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
915 _ _ |0 StatID:(DE-HGF)0310
|2 StatID
|a DBCoverage
|b NCBI Molecular Biology Database
915 _ _ |0 StatID:(DE-HGF)1030
|2 StatID
|a DBCoverage
|b Current Contents - Life Sciences
915 _ _ |0 StatID:(DE-HGF)1050
|2 StatID
|a DBCoverage
|b BIOSIS Previews
915 _ _ |0 StatID:(DE-HGF)9900
|2 StatID
|a IF < 5
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)GRS-20100316
|k GRS
|l GRS
|x 0
920 1 _ |0 I:(DE-Juel1)IAS-5-20120330
|k IAS-5
|l Computational Biomedicine
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)GRS-20100316
980 _ _ |a I:(DE-Juel1)IAS-5-20120330
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)INM-9-20140121
981 _ _ |a I:(DE-Juel1)IAS-5-20120330


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21